AUPH Q1 2019 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

AUPHAurinia Pharmaceuticals Inc.

$2B

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$30,000+0.0% YoY

Gross Profit

-$11M-35336.7% margin

Operating Income

-$15M-49616.7% margin

Net Income

-$12M-41426.7% margin

EPS (Diluted)

$-0.14

QoQ Revenue Growth

+3.4%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$165M

Total Liabilities

$25M

Stockholders' Equity

$139M

Cash & Equivalents

$140M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$30,000	$30,000	+0.0%
Gross Profit	-$11M	-$9M	-19.7%
Operating Income	-$15M	-$13M	-14.1%
Net Income	-$12M	-$15M	+19.7%